This fund typically commits a minimum of 80% of its total capital to the constituent securities of its underlying index, or to depositary receipts representing those index holdings. The benchmark index is crafted to monitor the financial performance of companies that derive a significant portion of their business and revenue from the healthcare technology sector. These enterprises are selected for their robust potential for expansion within this field, driven by pioneering innovation and the successful market integration of their products and services. It is important to note that the fund operates on a non-diversified basis.

Veeva Systems Inc.

Catalent, Inc.

Thermo Fisher Scientific Inc.

Incyte Corporation

Akoya Biosciences, Inc.

AxoGen, Inc.

Danaher Corporation

Regeneron Pharmaceuticals, Inc.

Fulgent Genetics, Inc.

Alnylam Pharmaceuticals, Inc.

Healthcare

Cash & Others

Financial Services

Technology

Industrials

Energy

ROBO Global Healthcare Technology and Innovation ETF

HTEC Holdings & Sector Breakdown

HTEC Holdings & Sector Breakdown